Proact study: New features of insulin pumps improve diabetes management and Glycemic control in patients after transition of continuous subcutaneous insulin infusion systems

Diabetes Technology and Therapeutics

Volumn 15, Issue 9, 2013, Pages 738-743

  Ziegler, Ralph ^a   Tubili, Claudio ^b   Chico, Ana ^c   Guerci, Bruno ^d   Lundberg, Elena ^e   Borchert, Marcus ^f   Löffler, Andrea ^f   Bloethner, Sandra ^g   Weissmann, Jörg ^g   Pfützner, Andreas ^h  

^a Clinic for Pediatric and Adolescent Diabetes   (Germany)

^b SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^c HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^d CHU NANCY BRABOIS   (France)

^e Skelleftea Hospital   (Sweden)

^f IKFE CRO GmbH   (Germany)

^g ROCHE DIAGNOSTICS GMBH   (Germany)

^h IKFE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; HUMAN INSULIN; INSULIN; INSULIN ASPART; INSULIN GLULISINE; INSULIN LISPRO; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN;

ADULT; ARTICLE; AUTOMATION; BLOOD GLUCOSE METER; BLOOD GLUCOSE MONITORING; CALCULATOR; CLINICAL EFFECTIVENESS; CONTINUOUS INFUSION; CONTINUOUS SUBCUTANEOUS INSULIN INFUSION; CONTROLLED STUDY; DIABETES CONTROL; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; INFUSION SYSTEM; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; INSULIN PUMP; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SAFETY; AGED; ANALYSIS; CLINICAL TRIAL; DIABETES MELLITUS; EUROPE; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; PROSPECTIVE STUDY; SUBCUTANEOUS DRUG ADMINISTRATION;

ADULT; AGED; BLOOD GLUCOSE; DIABETES MELLITUS; EUROPE; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INFUSIONS, SUBCUTANEOUS; INSULIN; INSULIN INFUSION SYSTEMS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 84883394381     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2013.0090     Document Type: Article

References (21)

1. Pickup JC: Insulin-pump therapy for type 1 diabetes mellitus. N Engl J Med 2012;366:1616-1624.
2. Didangelos T, Iliadis F: Insulin pump therapy in adults. Diabetes Res Clin Pract 2011;93(Suppl 1):S109-S113.
3. Hoogma RP, Hammond PJ, Gomis R, Kerr D, Bruttomesso D, Bouter KP, Wiefels KJ, de la Calle H, Schweitzer DH, Pfohl M, Torlone E, Krinelke LG, Bolli GB; 5-Nations Study Group: Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH-based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5-Nations Trial. Diabet Med 2006;23: 141-147.
4. Boland EA, Grey M, Oesterle A, Fredrickson L, Tamborlane WV: Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes. Diabetes Care 1999;22:1779-1784.
5. Paul N, Kohno T, Klonoff DC: A review of the security of insulin pump infusion systems. J Diabetes Sci Technol 2011;5:1557-1562.
6. Schmid V, Hohberg C, Borchert M, Forst T, Pfü tzner A: Pilot study for assessment of optimal frequency for changing catheters in insulin pump therapy-Trouble starts on day 3. J Diabetes Sci Technol 2010;4:976-982.
7. Herrero P, Calm R, Veh?́ J, Armengol J, Georgiou P, Oliver N, Tomazou C: Robust fault detection system for insulin pump therapy using continuous glucose monitoring. J Diabetes Sci Technol 2012;6:1131-1141.
8. Lepore G, Dodesini AR, Nosari I, Scaranna C, Corsi A, Trevisan R: Bolus calculator improves long-Term metabolic control and reduces glucose variability in pump-Treated patients with Type 1 diabetes. Nutr Metab Cardiovasc Dis 2012;22:e15-e16.
9. Selam JL: Evolution of diabetes insulin delivery devices. J Diabetes Sci Technol 2010;4:505-513.
10. Zisser H, Wagner R, Pleus S, Haug C, Jendrike N, Parkin C, Schweitzer M, Freckmann G: Clinical performance of three bolus calculators in subjects with type 1 diabetes mellitus: a head-To-head-To-head comparison. Diabetes Technol Ther 2010;12:955-961.
11. Schwartz FL, Vernier SJ, Shubrook JH, Marling CR: Evaluating the automated blood glucose pattern detection and case-retrieval modules of the 4 Diabetes Support System. J Diabetes Sci Technol 2010;4:1563-1569.
12. Lalic N, Tankova T, Nourredine M, Parkin C, Schweppe U, Amann-Zalan I: Value and utility of structured selfmonitoring of blood glucose in real world clinical practice: findings from a multinational observational study. Diabetes Technol Ther 2012;14:338-343.
13. Pimazoni-Netto A, Rodbard D, Zanella MT; Diabetes Education and Control Group: Rapid improvement of glycemic control in type 2 diabetes using weekly intensive multifactorial interventions: structured glucose monitoring, patient education, and adjustment of therapy-A randomized controlled trial. Diabetes Technol Ther 2011;13:997-1004.
14. Garg SK, Bookout TR, McFann KK, Kelly WC, Beatson C, Ellis SL, Gutin RS, Gottlieb PA: Improved glycemic control in intensively treated adult subjects with type 1 diabetes using insulin guidance software. Diabetes Technol Ther 2008;5:369-375.
15. Kerr D, Hoogma RP, Buhr A, Petersen B, Storms FE; Study Investigators: Multicenter user evaluation of ACCU-CHEK Combo, an integrated system for continuous subcutaneous insulin infusion. J Diabetes Sci Technol 2010;4:1400-1407.
16. Renard E: Insulin pump use in Europe. Diabetes Technol Ther 2010;12(Suppl 1):S29-S32.
17. American Diabetes Association: Standards of medical care in diabetes-2010. Diabetes Care 2010;33(Suppl 1):S11-S61.
18. Eugster EA, Francis G; the Lawson-Wilkins Drug and Therapeutics Committee: Position statement: continuous subcutaneous insulin infusion in very young children with type 1 diabetes. Pediatrics 2006;118:e1244-e1249.
19. Alsaleh F, Smith F, Keady S, Taylor K: Insulin pumps: from inception to the present and toward the future. J Clin Pharmacol Ther 2010;35:127-138.
20. Heinemann L: Insulin pump therapy: what is the evidence for using different types of boluses for coverage of prandial insulin requirements? J Diabetes Sci Technol 2009;3:1490-1500.
21. Kerr D, Olateju T: Pascal's wager: combining continuous glucose monitoring and continuous subcutaneous insulin infusion. Diabetes Technol Ther 2010;12(Suppl 1):S43-S50.